Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ANIK stock: Anika Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$56.56
Market Cap
787.2M
Sector
Health Care
Div. Growth
-
P/E
23.8
P/B
3.2
P/S
7.03
Dividend %
-
P/CF
28.1
P/FCF
26.5
Op. Cash Flow
38.5K
FCF
2.0
Op. Margin
46.90%
Net Margin
30.40%
ROE
14.90%
ROI
14.50%
ROA
13.80%
EPS Growth
-1.20%
Current Ratio
19.4
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
MGC Diagnostics Corp (MGCD) $8.02 - - 34.1M Strong Buy
Community Health Systems (CYH) $7.26 - - 876.8M Strong Buy
AMAG Pharmaceuticals, Inc. (AMAG) $18.45 - - 589.3M Strong Buy
InfuSystem Holdings Inc (INFU) $2.10 - - 43.2M Strong Buy
Champions Oncology Inc (CSBR) $3.62 - - 33.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More